Prevention and treatment of cutaneous lupus erythematosus
AssigneeCBio Limited
InventorsHans-Joachim Anders, Dean Jason Naylor, Richard James Brown, Walter Rene Antonius Van Heumen
Life of this patent
Estimating the term…
Abstract
Disclosed herein, in certain embodiments, are methods and compositions for the prevention and treatment of autoimmune disease. Further disclosed herein, in certain embodiments, are methods for the prevention and treatment of cutaneous lupus erythematosus. Additionally disclosed herein, in certain embodiments, are compositions for the prevention and treatment of cutaneous lupus erythematosus.
Claims25
A method for preventing or treating cutaneous lupus erythematosus in a subject, the method comprising administering a therapeutically effective amount of a chaperonin 10 (Cpn10) polypeptide to the subject.
Use of a chaperonin 10 (Cpn10) polypeptide in the preparation of a medicament for the prevention or treatment of cutaneous lupus erythematosus.
A composition comprising a chaperonin 10 (Cpn10) polypeptide and at least one additional agent for the treatment of cutaneous lupus erythematosus.
Dependencies are inferred from the claim text.